order to obtain better yields and shorter reaction times [12] . Although the thieno[c]-and thieno [£>]-naphthyridines are much more deactivated towards electrophilic substitution, it was possible to achieve bromination under forced conditions [13] , The photoelectron spectra of the thienonaphthyridines have also been studied in detail [14, 15] .
The reaction path of this one-pot method for the preparation of tricyclic heterocyclic systems with angular annelation consists of Pd(0)-catalyzed carbon-carbon bond formation followed by ring-closure through reaction of the formyl group with the amino function. In some cases spontaneous aromatization occurs by elimination of water. In other cases this is achieved by reaction with dilute hydrochloric acid (scheme 1) [ We were therefore interested in expanding our investigations to imidazo [4,5-d] thieno [b] pyridines to study reactivity and spectral properties and especially, as imidazole is an important building block for several biologically active compounds [19] . Suzuki and co-workers have reported anti-inflammatory [20] and bronchodilating [21, 22] effects for some heterocyclic tricycles containing imidazole (1 and 2). It should therefore be of interest to prepare and study the properties of compounds in which the pyridino and benzo moiety of 1 and 2 is changed to thiopheno as in compounds of type 3.
As in the preparation of the thieno [b]napthyridines, two strategies can be used for the preparation of
R=simple alkyl 3a : R2=H 3b : R2=CH 3 3c : R 2 =CH 2 Ph the parent imidazo-fused compounds. Either o-formylhaloimidazoles could be coupled with o-amino(trialkylstannyl)thiophenes or o-formyltrialkylstannyl)imidazoles are coupled with protected o-aminohalothiophenes. In this paper the results of the first-mentioned approach will be described.
Experimental
The reactions were carried out in dried glassware. Reagents and solvents were handled by using standard syringe techniques. The starting materials 2,4,5-tribromoimidazole [23] , 2,4,5-triiodoimidazole (6) [24, 25] , 4-iodoimidazole (7a) [24, 26] , i-butyl /V--(2-trimethylstannyl-3-thienyl)carbamate (10) [12] , f-butyl A/-3-trimethylstannyl-3-thienyl)carbamate (11) [12] , and i-butyl A/-(4-trimethylstannyl-3-thienyl)-carbamate (12) [12] were prepared according to literature procedures. Uncorrected melting points were determined using a Wetzlar microscope. The 1 H NMR spectra were recorded on a Varian XL-300 spectrometer. Chemical shifts are reported in parts per million downfield from TMS. The mass spectra were recorded on a Jeol JMS-SX 102 spectrometer. Flash column chromatography was carried out using Merck silica gel 60. Heptane, pentane, ethyl acetate, dichloromethane and tetrachloromethane were freshly distilled over molecular sieves, chloroform over phosphorous pentoxide, diethyl ether and tetrahydrofuran from sodium dispersion prior to use. For HPLC a preparative polygosil/silica column (250x20 mm) was used. 
4-lodo-1-methylimidazole (7d).
A suspension of 250 mg (10.3 mmol) of sodium hydride in 5.0 ml of anhydrous tetrahydrofuran was treated dropwise with 2.00 g (10.3 mmol) of 4-iodoimidazole (7a) [24, 26] in 20 ml of anhydrous tetrahydrofuran. After stirring for 15 minutes 1.92 ml (10.3 mmol) of methyl p-toluenesulphonate in 10.0 ml of anhydrous tetrahydrofuran was added dropwise. After 45 minutes the starting materials were consumed and water was added. The product was extracted with ether. The combined organic phases were washed with aqueous sodium chloride solution and purified by column chromatography on silica, using methanol/dichloromethane (1:9) as eluent. The yield after purification was 1.53 g (71 %). 
5-Hydroxymethyl-4-iodoimidazole (8a).
A mixture of 8.00 g (41 mmol) of 4-iodoimidazole (7a), 5.74 g (70 mmol) of sodium acetate, 3.50 ml (62 mmol) of acetic acid and 29 ml of 37% formaldehyde was refluxed for 28 h. The reaction mixture was cooled and mixed with 325 ml of water The resulting mixture was made weakly alkaline 
5-Hydroxymethyl-4-iodo-1-methylimidazole (8b).
As described above for 14a, 4.20 g (20 mmol) of 1-methyl-4-iodoimidazole (7d) was hydroxymethy- 
4-lodo-5-imidazolecarboxaldehyde (9a).
To 100 mg (0.45 mmol) of 5-hydroxymethyl-4-iodolimidazole (8a) in 4.5 ml of 1,4-dioxane 390 mg 
4-lodo-1 -methyl-5-imidazolecarboxaldehyde (9b).
To 100 mg (0.42 mmol) of 4-iodo-1-methyl-5-hydroxymethylimidazole (8b) in 7.5 ml of chloroform 420 mg (4.2 mmol) of activated manganese(IV)oxide was added. The mixture was refluxed for 1.5 h and worked up as described for 9a. The title compound was obtained in a yield of 850 mg (85%). 
5-Benzyloxymethylimidazo^.S-cflthienoß^-blpyridine (13a).
To 4.0 ml of anhydrous Λ/,/V-dimethylformamide 370 mg (1,25 mmol) of 1-benzyloxymethyl-4-bromo-5-formylimidazole (5b), 70 mg (0.06 mmol) of fefra/c/s(triphenylphosphine)palladium(0) [28] and 100 mg (1.25 mmol) of cupric oxide were added. The reaction mixture was heated to 100 °C and after 5 minutes 650 mg (1.80 mmol) of f-butyl-W-(2-trimethylstannyl-3-thienyl)carbamate (10) [12] in approximately 1 h) the reaction mixture was cooled to room temperature. After evaporation, the residue was dissolved in ether and the black precipitate filtered off. The crude product was purified by column chromatography on silica, using acetone/heptane (6:4) as eluent. 
3-Benzyloxymethylimidazo[4,5-d]thieno[2,3-i>]pyridine (14).
This compound was prepared from 370 mg (1. with excess sodium sulfite in 30 % aqueous ethanol [24, 26, 31] , followed by hydroxymethylation to 8
with formaldehyde in an acetic acid/sodium acetate buffer (pH = 4.6) [29, 32, 33] and a final oxidation to the aldehyde, 9, using activated manganese(IV)-oxide [29, [34] [35] [36] . According to the literature [32, 33, 37 ] Nprotected imidazoles provide 2-hydroxymethylimidazoles while 2-alkylated and/or imidazoles with an free NH group give the 5-hydroxymethyl derivative.
Ohba etal. [29] claimed that hydroxymethylation of 4-bromo-1-methylimidazole (7c) resulted in the 5-hydroxymethyl isomer in 76 % yield. Masui et at.
[33] hydroxymethylated 2,4-dialkylated imidazole derivatives with a free NH group, achieving 5-hydroxymethylated compounds with yields varying between 11 and 27 %. We obtained a yield of only 13 % of 5-hydroxymethyl-4-iodoimidazole (8a), when the procedure described by Masui and co-workers [33] was employed. This low yield was not surprising, in the light of the fact that varying yields in the hydroxymethylation of imidazoles, with especially low yield for 4-bromoimidazole (7b) has been reported previously [38] , Hydroxymethylation is facilitated by electron-releasing groups, such as the methyl group. In order to increase the yield, 4-iodo-1-methylimidazole (7d) was therefore prepared and subsequently hydroxymethylated under the same conditions as used for 4-iodoimidazole (7a). This led to complete conversion as judged by thin layer chromatography, however only 13 % of 5-hydroxymethyl-4-iodo-1-methylimidazole (8b) could be isolated after work-up and purification according to Masui et at. [33] . Modification of the work-up procedure, avoiding distillation of the combined organic extracts and instead evaporating off the solvent over night resulted in an increased yield of 8b of 47 %. This procedure combined with exrac- tion with dichloromethane of the evaporated water phase from 7a, raised the yield of 5-hydroxymethyl-4-iodoimidazole (9a) to a modest 19%. Oxidation with activated manganese(IV)oxide in refluxing chloroform [29] resulted in 85 % yield of 4-iodo-1-methyl-5-imidazolecarboxaldehyde (9b) after 1.5 hours. As 8a was not soluble in chloroform it was heated with activated manganese(IV) oxide in dioxane at 80 °C for two hours [34, 35, 36] giving 9a in a yield of 66%.
Coupling of the imidazoles 5a and 5b with the three isomeric f-butyl /V-(o-trimethylstannyl-thienyl)- The two aldehydes 9a and 9b were reacted with (10) under the same conditions as described above gave the best results yielding 1-methylimidazo [4,5-d] thieno [3,2-b] pyridine (13c) in a yield of 82 %.
However, 9a did not give the desired compound 13b.
Conclusions.
Our preliminary results show that the biologically interesting imidazo [4,5- 
